Management of refractory dyspnoea in COPD

D. Janssen (Horn, Netherlands)

Source: Virtual Congress 2021 – Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Janssen (Horn, Netherlands). Management of refractory dyspnoea in COPD. Virtual Congress 2021 – Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Management of chronic breathlessness
Source: Eur Respir Monogr 2016; 73: 153-171
Year: 2016


Chronic refractory cough
Source: Virtual Congress 2020 – Clinical grand round: revisiting current guidelines
Year: 2020


Determinants of dyspnea in stable COPD patients
Source: Annual Congress 2011 - COPD management
Year: 2011

Management of acute COPD exacerbations
Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention
Year: 2013


Respiratory depression secondary to morphine use in a patient with COPD and refractory breathlessness
Source: Eur Respir J, 49 (5) 1601858; 10.1183/13993003.01858-2016
Year: 2017



Management of refractory dyspnoea in end-stage patients: the use of noninvasive respiratory support
Source: Virtual Congress 2021 – Noninvasive respiratory support in hypoxic respiratory failure: stay safe and know your limits
Year: 2021


Management of COPD exacerbations
Source: ERS Lung Science Conference 2019
Year: 2019


Non-pharmacological management of dyspnoea and cough in COPD
Source: International Congress 2014 – Primary Care Programme "Management of COPD and other respiratory conditions in clinical practice"
Year: 2014

Mechanisms of exertional dyspnoea in symptomatic smokers without COPD
Source: Eur Respir J 2016; 48: 694-705
Year: 2016



Evaluation of nasal optiflow device in management of COPD patients in acute exacerbations
Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning
Year: 2015

Acute management of COPD exacerbations
Source: Annual Congress 2012 - ERS COPD exacerbation guidelines: methodologies and overview
Year: 2012


Relationship between dyspnea and depression in the elderly patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

Chronic cough in COPD
Source: Annual Congress 2003 - New pathophysiological aspects in COPD
Year: 2003

Outcome of pulmonary rehabilitation in patients after acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013

Overdiagnosis of COPD and asthma among elderly with chronic dyspnea
Source: Virtual Congress 2021 – Primary care diagnosis and multimorbidities
Year: 2021


Impact of anemia on dyspnea on exertion and exercise tolerance in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Exercise assessment in different diseases
Year: 2011


Mechanisms of orthopnea in patients with advanced COPD
Source: International Congress 2019 – Pathophysiological aspects of obstructive sleep apnoea from sea level to high altitude
Year: 2019


Assessing COPD profiles and outcomes by dyspnoea severity
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016


Strategy for the intractable pneumothoracs treatment in the patients with COPD
Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery
Year: 2008